We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
Scientist Jennifer Doudna on making CRISPR technology viable — and affordable — for everyone
While global cooperation on public health issues like access to COVID vaccines continues to sputter, a group of scientists from around the world are quietly working on making CRISPR gene-editing technology within reach for rich and poor nations alike. "We're going to want to work as quickly as possible to scale it to a point where that also helps bring down the cost," says Jennifer Doudna, who won the 2020 Nobel Prize in Chemistry for her work on CRISPR. Watch her interview with Ian Bremmer on GZERO World.
Watch the episode: CRISPR gene editing and the human race
What is CRISPR? Gene editing pioneer Jennifer Doudna explains
What is CRISPR? Jennifer Doudna explains You may have heard of CRISPR, but don't know exactly what it is, or how it works. Ian Bremmer asked Jennifer Doudna, who won the 2020 Nobel Prize in Chemistry for her work on this gene-editing technology. CRISPR, she says, basically allows scientists to not only study but also make precise, targeted changes to DNA, the "code of life." Find out more in her interview on GZERO World.
Watch the episode: https://www.gzeromedia.com/crispr-gene-editing-and-the-human-race
- CRISPR gene-editing tech should have limits, says Nobel laureate ... ›
- Podcast: Gene editing tech risks and rewards: Dr. Jennifer Doudna's ... ›
- Twitter bans QAnon; CRISPR gene tech - GZERO Media ›
- Ian Explains: Will biotech breakthroughs lead to super humans? - GZERO Media ›
- From CRISPR to cloning: The science of new humans - GZERO Media ›
CRISPR gene editing and the human race
Berkeley scientist Jennifer Doudna won the 2020 Nobel Prize for her work on the revolutionary gene-editing technology known as CRISPR. It has the potential to cure genetic diseases like sickle cell anemia and hereditary blindness and may even be used to treat cancer and HIV. But when it comes to editing humanity, where do we draw the line? How do we avoid falling into the same kind of dystopian nightmare outlined in Blade Runner? Doudna discussed the risks and benefits of CRISPR in an interview with Ian Bremmer on GZERO World. Also in this episode: a look at cloning our pets (speaking of going too far…).
- CRISPR gene-editing tech should have limits, says Nobel laureate ... ›
- Podcast: Gene editing tech risks and rewards: Dr. Jennifer Doudna's ... ›
- Twitter bans QAnon; CRISPR gene tech - GZERO Media ›
- Ian Explains: Will biotech breakthroughs lead to super humans? - GZERO Media ›
- Podcast: Tracking the rapid rise of human-enhancing biotech with Siddhartha Mukherjee - GZERO Media ›
- From CRISPR to cloning: The science of new humans - GZERO Media ›
- CRISPR, AI, and cloning could transform the human race - GZERO Media ›
Podcast: Gene editing tech risks and rewards: Dr. Jennifer Doudna's perspective
Listen: In a wide-ranging interview with Ian Bremmer, Nobel Prize-winning scientist Jennifer Doudna discusses her groundbreaking work on the revolutionary gene-editing technology known as CRISPR. In their conversation she explains what CRISPR is and why it has the potential to cure diseases and fend off viruses. She also talks about the limits of this technology and advocates for a global policy consensus on what limitations there should be around gene editing. Policymakers must also factor in income inequality, Doudna argues, given how expensive CRISPR currently is and the potential it has to change so many lives.
Subscribe to the GZERO World Podcast on Apple Podcasts, Spotify, Stitcher, or your preferred podcast platform, to receive new episodes as soon as they're published.
CRISPR gene-editing tech should have limits, says Nobel laureate Jennifer Doudna
For Jennifer Doudna, who won the 2020 Nobel Prize in Chemistry for her work on CRISPR gene editing, there are some red lines we shouldn't cross (yet). The technology, she says, has "the potential to do incredible things and make incredible advances that will be beneficial to our society, but hand-in-hand with that go these large risks." One is human embryos, but that doesn't mean that in the future we shouldn't be able to use CRISPR on ourselves, for instance to protect us from diseases. Watch her interview with Ian Bremmer on GZERO World.